Sulfasalazine-induced Angioimmunoblastic lymphadenopathy developing in a patient with juvenile chronic arthritis

Citation
S. Pay et al., Sulfasalazine-induced Angioimmunoblastic lymphadenopathy developing in a patient with juvenile chronic arthritis, RHEUM INTL, 20(1), 2000, pp. 25-27
Citations number
16
Categorie Soggetti
Rheumatology,"da verificare
Journal title
RHEUMATOLOGY INTERNATIONAL
ISSN journal
01728172 → ACNP
Volume
20
Issue
1
Year of publication
2000
Pages
25 - 27
Database
ISI
SICI code
0172-8172(200012)20:1<25:SALDIA>2.0.ZU;2-7
Abstract
We describe a patient with juvenile chronic arthritis who developed reactiv e angioimmunoblastic lymphadenopathy, induced by sulfasalazine. Development of angioimmunoblastic lymphadenopathy although rare, is a very serious sid e effect of sulfasalazine treatment, and patients treated with this drug sh ould be watched carefully.